Olanzapine-induced hyperglycemia in anorexia nervosa [10]

American Journal of Psychiatry

Volumn 164, Issue 3, 2007, Pages 528-529

  Yasuhara, Daisuke ^a   Nakahara, Toshihiro ^a   Harada, Toshiro ^a   Inui, Akio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTAMATE DECARBOXYLASE ANTIBODY; OLANZAPINE;

ADULT; AGITATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA NERVOSA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CALORIC INTAKE; CASE REPORT; DIABETES MELLITUS; DRUG MECHANISM; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; LABORATORY TEST; LETTER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL;

EID: 34047191886     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.3.528a     Document Type: Letter

References (6)

1. Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P: Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Australas Psychiatry 2005; 13:72-75
2. Barbarich NC, McConaha CW, Gaskill J, La Via M, Frank GK, Achenbach S, Plotnicov KH, Kaye WH: An open trial of olanzapine in anorexia nervosa. J Clin Psychiatry 2004; 65:1480-1482
3. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. J Clin Psychiatry 2004; 65:267-272
4. Yasuhara D, Naruo T, Nagai N, Muranaga T, Nakahara T, Tanaka M, Kojima S, Sagiyama K, Masuda A, Inui A: Glucose tolerance predicts short-term refeeding outcome in females with anorexia nervosa. Psychosom Med 2005; 67:669-676
5. Engl J, Laimer M, Niederwanger A, Kranebitter M, Starzinger M, Pedrini MT, Fleischhacker WW, Patsch JR, Ebenbichler CF: Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells. Mol Psychiatry 2006; 11:524-525
6. Fatemi SH, Reutiman TJ, Folsom TD, Bell C, Nos L, Fried P, Pearce DA, Singh S, Siderovski DP, Willard FS, Fukuda M: Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique. Neuropsychopharmacology 2006; 31:1888-1899